Scandion Oncology investor relations material
Listen to the latest call from Scandion Oncology
Scandion Oncology A/S is a clinical-stage biotechnology company, which focuses on developing medicines for the treatment of chemotherapy resistance. Scandion Oncology A/S was founded in 2017 and is headquartered in Copenhagen, Denmark.
Ticker
SCOLCountry
SEAbout
IR-page
Upcoming events
Dig deeper into the Scandion Oncology fundamentals on Quartr.
